title: [Efficacy and safety of transcranial magnetic stimulation in the treatment of rare forms of muscular dystonia].
abstract: OBJECTIVE
  To evaluate the efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) for the treatment of patients with dystonia.
  
  
  METHODS
  Authors treated 66 patients with segmental and generalized forms of dystonia, writer's cramp and oromandibular dystonia. The degree of dystonia severity was assessed using the Burke--Fahn--Marsden scale.
  
  
  CONCLUSIONS
  rTMS treatment of the motor cortex region decreased dystonic hyperkinesis severity. There was a significant decrease in scores on the Burke--Fahn--Marsden scale (p<0.05). This method was well-tolerated. No side-effects were observed, with the exception of one patient, who wished to discontinue treatment because of the twitching of facial muscles during rTMS. The results of the study allow to recommend wider adoption of this method in complex treatment and rehabilitation of patients with rare forms of dystonia.
authors.affiliation: Republican Research and Clinical Centre of Neurology and Neurosurgery, Minsk, Belarus.
authors.forename: S A
authors.initials: SA
authors.lastname: Likhachev
authors.affiliation: Republican Research and Clinical Centre of Neurology and Neurosurgery, Minsk, Belarus.
authors.forename: T N
authors.initials: TN
authors.lastname: Charnukha
authors.affiliation: Republican Research and Clinical Centre of Neurology and Neurosurgery, Minsk, Belarus.
authors.forename: G V
authors.initials: GV
authors.lastname: Zabrodzets
authors.affiliation: Republican Research and Clinical Centre of Neurology and Neurosurgery, Minsk, Belarus.
authors.forename: O V
authors.initials: OV
authors.lastname: Gleb
mesh_terms: D000328:Adult; D004421:Dystonia / Q000473:pathology / Q000628:therapy*; D020821:Dystonic Disorders / Q000503:physiopathology / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D050781:Transcranial Magnetic Stimulation / Q000009:adverse effects* / Q000379:methods*; D016896:Treatment Outcome